Stuart E Starr
Affiliation: The Children's Hospital of Philadelphia
- Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 TeamS E Starr
Division of Immunologic and Infectious Diseases, Children s Hospital of Philadelphia, PA 19104, USA
N Engl J Med 341:1874-81. 1999....
- Efavirenz liquid formulation in human immunodeficiency virus-infected childrenStuart E Starr
Division of Infectious and Immunologic Diseases, Abramson Research Center, The Children s Hospital of Philadelphia, PA 19104, USA
Pediatr Infect Dis J 21:659-63. 2002....
- Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected childrenStuart E Starr
Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA
AIDS 17:2181-9. 2003..To define the tolerated dose of recombinant interleukin-2 (rIL-2) in HIV-infected children (part A), and to determine the safety and immunologic effects of the tolerated rIL-2 dose in a cohort of HIV-infected children (part B)...
- Increased proliferation within T lymphocyte subsets of HIV-infected adolescentsStuart E Starr
Department of Pediatrics, Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 4318, USA
AIDS Res Hum Retroviruses 18:1301-10. 2002..The Ki-67 assay provided new and useful information on in vivo lymphocyte proliferation in HIV-infected adolescents...